参考文献/References:
[1] Thygesen K, Alpert JS, Jaffe AS, et al. Fourth Universal definition of myocardial infarction (2018)[J]. Glob Heart,2018,13(4):305-338.
[2] Saaby L, Poulsen TS, Hosbond S, et al. Classification of myocardialinfarction: frequency and features of type 2 myocardial infarction[J]. Am J Med, 2013,126(9):789-797.
[3] Hijazi Z, Oldgren J, Andersson U, et al. Cardiac biomarkers are associated with an increased risk of stroke and death in patients with atrial fibrillation: a Randomized Evaluation of Long-term Anticoagulation Therapy (RE-LY) substudy[J]. Circulation, 2012,125(13):1605-1616.
[4] Chen JF, Smilowitz NR, Kim JT, et al. Medical therapy for atherosclerotic cardiovascular disease in patients with myocardial injury after non-cardiac surgery[J]. Int J Cardiol, 2019,279: 1-5.
[5] Gualandro DM, Campos CA, Calderaro D, et al. Coronary plaque rupture in patients with myocardial infarction after noncardiac surgery: frequent and dangerous[J]. Atherosclerosis, 2012,222(1):191-195.
[6] Samman TA, Sandesara P, Hayek SS, et al. High-sensitivity troponin I levels and coronary artery disease severity, progression, and long-term outcomes[J]. J Am Heart Assoc,2018,7(5):e007914.
[7] Alpert JS, Thygesen KA, White HD, et al. Diagnostic and therapeutic implications of type 2 myocardial infarction: review and commentary[J]. Am J Med, 2014,127(2):105-108.
[8] White HD. Pathobiology of troponin elevations: do elevations occur with myocardial ischemia as well as necrosis?[J]. J Am Coll Cardiol, 2011,57(24):2406-2408.
[9] Park KC, Gaze DC, Collinson PO, et al. Cardiac troponins: from myocardial infarction to chronic disease[J]. Cardiovasc Res, 2017, 113(14):1708-1718.
[10] Costabel JP, Burgos LM, Trivi M. The Significance of troponin elevation in atrial fibrillation[J]. J Atr Fibrillation,2017,9(6):1530.
[11] Chin CW, Shah AS, McAllister DA, et al. High-sensitivity troponin I concentrations are a marker of an advanced hypertrophic response and adverse outcomes in patients with aortic stenosis[J]. Eur Heart J, 2014,35(34): 2312-2321.
[12] Chapman AR, Adamson PD, Mills NL. Assessment and classification of patients with myocardial injury and infarction in clinical practice[J]. Heart,2017,103(1):10-18.
[13] Vasile VC, Chai HS, Abdeldayem D, et al. Elevated cardiac troponin T levels in critically ill patients with sepsis[J]. Am J Med, 2013,126(12):1114-1121.
[14] Thygesen K, Mair J, Giannitsis E, et al. How to use high-sensitivity cardiac troponins in acute cardiac care[J]. Eur Heart J, 2012,33(18):2252-2257.
[15] Chapman AR, ASV S, Lee KK, et al. Long-term outcomes in patients with type 2 myocardial infarction and myocardial injury[J].Circulation,2018,137(12): 1236-1245.
[16] Radovanovic D, Pilgrim T, Seifert B, et al. Type 2 myocardial infarction: incidence, presentation, treatment and outcome in routine clinical practice[J]. J Cardiovasc Med, 2017,18(5):341-347.
相似文献/References:
[1]冯泽豪 姜萌 卜军.心脏磁共振评价化疗所致心肌损伤的研究进展[J].心血管病学进展,2019,(5):667.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.003]
FENG Zehao,JIANG Meng,PU Jun.Cardiovascular Magnetic Resonance for Detection of Myocardial Impairments Caused by Chemotherapy[J].Advances in Cardiovascular Diseases,2019,(9):667.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.003]
[2]布热比古力·阿布力米提 付真彦.乳腺癌药物治疗与心肌损伤[J].心血管病学进展,2020,(8):802.[doi:10.16806/j.cnki.issn.1004-3934.2020.08.005]
Burebiguli·abulimitiFU Zhenyan.Drug Therapy of Breast Cancer and Assosiated Myocardial Damage[J].Advances in Cardiovascular Diseases,2020,(9):802.[doi:10.16806/j.cnki.issn.1004-3934.2020.08.005]
[3]陈涛 张大勇 袁明 魏天龙.急性ST段抬高型心肌梗死患者血miRNA-499a与心肌损伤标志物的相关性分析[J].心血管病学进展,2020,(9):994.[doi:10.16806/j.cnki.issn.1004-3934.2020.09.025]
CHEN Tao,ZHANG Dayong,YUAN Ming,et al.Correlation Between Serum miRNA-499a and Myocardial Injury Markers in Patients with Acute ST-Segment Elevation Myocardial Infarction[J].Advances in Cardiovascular Diseases,2020,(9):994.[doi:10.16806/j.cnki.issn.1004-3934.2020.09.025]
[4]汪汉,刘汉雄,蔡琳.2019冠状病毒病的心血管表现[J].心血管病学进展,2020,(11):1152.[doi:10.16806/j.cnki.issn.1004-3934.2020.11.000]
WANG Han,LIU Hanxiong,CAI Lin.Cardiovascular Profiles in Corona V irus Disease 2019[J].Advances in Cardiovascular Diseases,2020,(9):1152.[doi:10.16806/j.cnki.issn.1004-3934.2020.11.000]
[5]庞泽堃 李剑明.放射性核素分子显像在心肌损伤中的研究进展[J].心血管病学进展,2023,(1):25.[doi:10.16806/j.cnki.issn.1004-3934.2023.01.007]
PANG Zekun,LI Jianming.Radionuclide Molecular Imaging in Myocardial Injury[J].Advances in Cardiovascular Diseases,2023,(9):25.[doi:10.16806/j.cnki.issn.1004-3934.2023.01.007]
[6]田振宇 刘燕娥 朱丹 曹宝山 崔鸣.肿瘤化疗心肌损伤机制及其与肠道菌群相关性的研究进展[J].心血管病学进展,2023,(6):496.[doi:10.16806/j.cnki.issn.1004-3934.2023.06.004]
TIAN Zhenyu,LIU Yane,ZHU Dan,et al.Progress of the Mechanism of Myocardial Injury and its Correlation between Tumor Chemotherapy and Intestinal Microbiota[J].Advances in Cardiovascular Diseases,2023,(9):496.[doi:10.16806/j.cnki.issn.1004-3934.2023.06.004]
[7]袁敏?韩轩茂?蔺雪峰.纳米氧化铈抗氧化保护心肌细胞的研究进展[J].心血管病学进展,2023,(7):654.[doi:10.16806/j.cnki.issn.1004-3934.2023.07.018]
YUAN Min,HAN Xuanmao,LIN Xuefeng.Cerium Oxide Nanoparticles in Antioxidant Protection of M yocardial?ells?/html>[J].Advances in Cardiovascular Diseases,2023,(9):654.[doi:10.16806/j.cnki.issn.1004-3934.2023.07.018]
[8]冉黔松 周厚荣.长链非编码RNA调节自噬在心肌缺血再灌注损伤中的研究进展[J].心血管病学进展,2024,(3):238.[doi:10.16806/j.cnki.issn.1004-3934.2024.03.011]
RAN Qiansong ZHOU Hourong.Long Non-Coding RNA Regulating Autophagy in Myocardial Ischemia-Reperfusion Injury[J].Advances in Cardiovascular Diseases,2024,(9):238.[doi:10.16806/j.cnki.issn.1004-3934.2024.03.011]